PHARMAPATENT AS

9415 HARSTAD

Finances

Return on Equity

11,11 %

Current Ratio

3,7

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	368 000	300 000	670 000	567 000
Net Income	295 000	266 000	545 000	357 000
Total Assets	3 123 000	2 725 000	2 566 000	2 168 000
Total Equity	2 656 000	2 661 000	2 395 000	1 850 000

Income (NOK)	2022	2021	2020	2019
Revenue	368 000	300 000	670 000	567 000
Expenditure	20 000	79 000	46 000	114 000
Operating Profit	349 000	222 000	624 000	453 000
Financial Income	23 000	91 000	59 000	9 000
Financial Costs	0	0	1 000	3 000
Financial Balance	23 000	91 000	58 000	6 000
Earnings Before Tax	371 000	312 000	682 000	459 000
Tax	77 000	46 000	137 000	102 000
Net Income	295 000	266 000	545 000	357 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 397 000	1 397 000	1 397 000	241 000
Total Current Assets	1 726 000	1 329 000	1 169 000	1 927 000
Total Assets	3 123 000	2 725 000	2 566 000	2 168 000
Total Retained Equity	2 556 000	2 561 000	2 295 000	1 750 000
Total Equity	2 656 000	2 661 000	2 395 000	1 850 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	467 000	64 000	171 000	318 000
Total Equity and Debt	3 123 000	2 725 000	2 566 000	2 168 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	368 000	300 000	670 000	567 000
Other Income	0	0	0	0
Revenue	368 000	300 000	670 000	567 000
Cost of Goods Sold	0	0	0	0
Salary Costs	0	65 000	−5 000	63 000
Depreciation	0	0	4 000	12 000
Impairment	0	0	0	0
Expenditure	20 000	79 000	46 000	114 000
Operating Profit	349 000	222 000	624 000	453 000
Financial Income	23 000	91 000	59 000	9 000
Financial Costs	0	0	1 000	3 000
Financial Balance	23 000	91 000	58 000	6 000
Dividends	300 000	0	0	0
Net Income	295 000	266 000	545 000	357 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	4 000
Total Tangible Assets	0	0	0	4 000
Total Fiancial Fixed Assets	1 397 000	1 397 000	1 397 000	237 000
Total Fixed Assets	1 397 000	1 397 000	1 397 000	241 000
Stock	0	0	0	0
Total Investments	599 000	576 000	486 000	850 000
Cash, Bank	1 075 000	693 000	531 000	886 000
Total Current Assets	1 726 000	1 329 000	1 169 000	1 927 000
Total Assets	3 123 000	2 725 000	2 566 000	2 168 000
Total Equity	2 656 000	2 661 000	2 395 000	1 850 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	0	0	3 000	0
Unpaid Taxes	90 000	17 000	30 000	95 000
Dividends	300 000	0	0	0
Other Current Debt	1 000	1 000	1 000	121 000
Total Current Debt	467 000	64 000	171 000	318 000
Total Equity and Debt	3 123 000	2 725 000	2 566 000	2 168 000

Financial indicators	2022	2021	2020	2019
Return on Equity	11,11 %	10 %	22,76 %	19,3 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	94,84 %	74 %	93,13 %	79,89 %
Current Ratio	3,7	20,77	6,84	6,06
Quick Ratio	3,7	20,77	6,84	6,06
Equity Ratio	0,85	0,98	0,93	0,85
Gross Profit Margin	100 %	100 %	100 %	100 %